20/20 BIOLABS, INC. Debt Conversion, Converted Instrument, Amount
20/20 BIOLABS, INC. (AIDX) reported Debt Conversion, Converted Instrument, Amount of $339.20 thousand for the 12-month period ending 2025-12-31, per its POS AM filed 2026-04-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-04-06
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2025-12-31 | $339.20K POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |